Annual CAPEX
N/A
30 April 2024
Summary:
PharmaCyte Biotech annual capital expenditures is not available.PMCB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
31 July 2024
Summary:
PharmaCyte Biotech quarterly capital expenditures is not available.PMCB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
31 July 2024
Summary:
PharmaCyte Biotech TTM capital expenditures is not available.PMCB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PMCB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
PharmaCyte Biotech CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2013 | $646.80 K(>+9900.0%) | - | - |
| Apr 2010 | - | -$46.30 K(<-9900.0%) | $0.00(-100.0%) |
| Jan 2010 | - | $0.00(0.0%) | $50.60 K(0.0%) |
| Oct 2009 | - | $0.00(-100.0%) | $50.60 K(-0.4%) |
| July 2009 | - | $46.30 K(+976.7%) | $50.80 K(+916.0%) |
| Apr 2009 | $5100.00(-75.7%) | $4300.00(>+9900.0%) | $5000.00(+284.6%) |
| Jan 2009 | - | $0.00(-100.0%) | $1300.00(-113.7%) |
| Oct 2008 | - | $200.00(-60.0%) | -$9500.00(-155.9%) |
| July 2008 | - | $500.00(-16.7%) | $17.00 K(-19.0%) |
| Apr 2008 | $21.00 K | $600.00(-105.6%) | $21.00 K(-104.6%) |
| Jan 2008 | - | -$10.80 K(-140.4%) | -$457.40 K(-162.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2007 | - | $26.70 K(+493.3%) | $727.70 K(+3.8%) |
| July 2007 | - | $4500.00(-100.9%) | $701.00 K(+0.6%) |
| Apr 2007 | $696.50 K(+9573.6%) | -$477.80 K(-140.7%) | $696.50 K(-40.9%) |
| Jan 2007 | - | $1.17 M(>+9900.0%) | $1.18 M(>+9900.0%) |
| Apr 2006 | $7200.00(-84.0%) | $4100.00(>+9900.0%) | $7200.00(+132.3%) |
| Jan 2006 | - | $0.00(-100.0%) | $3100.00(0.0%) |
| Oct 2005 | - | $2000.00(+81.8%) | $3100.00(-114.2%) |
| July 2005 | - | $1100.00(-104.8%) | -$21.80 K(<-9900.0%) |
| Oct 2004 | - | -$22.90 K(-200.0%) | $0.00(-100.0%) |
| July 2004 | - | $22.90 K | $22.90 K |
| Apr 2004 | $45.00 K | - | - |
FAQ
- What is the all time high annual CAPEX for PharmaCyte Biotech?
- What is the all time high quarterly CAPEX for PharmaCyte Biotech?
- What is the all time high TTM CAPEX for PharmaCyte Biotech?
What is the all time high annual CAPEX for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual capital expenditures is $696.50 K
What is the all time high quarterly CAPEX for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly capital expenditures is $1.17 M
What is the all time high TTM CAPEX for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM capital expenditures is $1.18 M